نبذة تعريفية / مختصر السيرة الذاتية
Summary
Wael Alanazi earned his Bachelor’s degree in Pharmaceutical Sciences from King Saud University in 2011. After graduation, he worked in the Drug Sector at the Saudi Food and Drug Authority (SFDA), where he was involved in the evaluation of the quality of pharmaceutical products.
In 2012, he joined the Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, as a teaching assistant. In 2013, he began his doctoral research in the Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, USA. There, he joined Dr. Jackson’s laboratory and completed his thesis entitled “The role of recurrent insulin-induced hypoglycemia on renal prostanoids production, (pro)renin receptor expression, and oxidative stress in the heart and kidney.”
In 2016, he earned his Ph.D. in Pharmacology and published several peer-reviewed articles. Following his Ph.D., he was appointed as an Assistant Professor at the College of Pharmacy, King Saud University. He was promoted to Associate Professor in 2021 and subsequently to Professor of Pharmacology in 2025. He is currently a Professor in the College of Pharmacy at King Saud University.
Research Interests
- Identify novel therapeutic strategies for prevention of diabetes-induced renal and cardiovascular diseases in various animal models of diabetes.
- Investigate the roles of renin angiotensin system, cyclooxygenases and oxidative stress in diabetic complications.
- Finding the link between blood glucose levels and different vicious pathways causing kidney damage and hypertension in hypoglycemic and/or hyperglycemic animal models.
- Study the antidiabetic activities of new synthetic compounds, and their mechanism of action in glycemic control.
